Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Response to catecholamine stimulation of polymorphisms of the beta-1 and beta-2 adrenergic receptors.

McLean RC, Baird SW, Becker LC, Townsend SN, Gerstenblith G, Kass DA, Tomaselli GF, Schulman SP.

Am J Cardiol. 2012 Oct 1;110(7):1001-7. doi: 10.1016/j.amjcard.2012.05.029. Epub 2012 Jun 27.

PMID:
22742717
2.

Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.

Lobmeyer MT, Gong Y, Terra SG, Beitelshees AL, Langaee TY, Pauly DF, Schofield RS, Hamilton KK, Herbert Patterson J, Adams KF Jr, Hill JA, Aranda JM Jr, Johnson JA.

Pharmacogenet Genomics. 2007 Apr;17(4):277-82.

PMID:
17496726
3.

[Interactions between beta1 and beta2 adrenergic receptor polymorphisms as risk factors for chronic heart failure].

Moraga F, Troncoso R, Mellado R, Díaz-Araya G, Vukasovic JL, Greig D, Perez O, García L, Roldán J, Ocaranza MP, Jali J, Chiong M, Castro P.

Rev Med Chil. 2008 Nov;136(11):1371-80. Spanish.

PMID:
19301767
4.

The Arg389Gly β1-adrenoceptor gene polymorphism influences the acute effects of β-adrenoceptor blockade on contractility in the human heart.

Huntgeburth M, La Rosée K, ten Freyhaus H, Böhm M, Schnabel P, Hellmich M, Rosenkranz S.

Clin Res Cardiol. 2011 Aug;100(8):641-7. doi: 10.1007/s00392-011-0288-1. Epub 2011 Feb 11.

PMID:
21311897
5.

β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.

Pereira SB, Velloso MW, Chermont S, Quintão MM, Nunes Abdhala R, Giro C, Oliveira E Alves T, Camacho V, De Fátima Maia Contarato L, Pena FM, Balieiro HM, Garcia ML, Da Nóbrega AC, Ribeiro GS, Mesquita ET.

Mol Med Rep. 2013 Jan;7(1):259-65. doi: 10.3892/mmr.2012.1120. Epub 2012 Oct 9.

PMID:
23064657
6.

Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure.

Wagoner LE, Craft LL, Zengel P, McGuire N, Rathz DA, Dorn GW 2nd, Liggett SB.

Am Heart J. 2002 Nov;144(5):840-6.

PMID:
12422153
7.

Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.

Biolo A, Clausell N, Santos KG, Salvaro R, Ashton-Prolla P, Borges A, Rohde LE.

Am J Cardiol. 2008 Sep 15;102(6):726-32. doi: 10.1016/j.amjcard.2008.04.070. Epub 2008 Jul 25.

PMID:
18773997
8.

Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.

Terra SG, Hamilton KK, Pauly DF, Lee CR, Patterson JH, Adams KF, Schofield RS, Belgado BS, Hill JA, Aranda JM, Yarandi HN, Johnson JA.

Pharmacogenet Genomics. 2005 Apr;15(4):227-34.

PMID:
15864115
9.

The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.

Bruck H, Leineweber K, Temme T, Weber M, Heusch G, Philipp T, Brodde OE.

J Am Coll Cardiol. 2005 Dec 6;46(11):2111-5. Epub 2005 Nov 4.

10.

Thr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy.

Barbato E, Penicka M, Delrue L, Van Durme F, De Bruyne B, Goethals M, Wijns W, Vanderheyden M, Bartunek J.

Heart. 2007 Jul;93(7):856-61.

11.

Association of beta-adrenoceptor polymorphisms with cardiac autonomic modulation in Japanese males.

Matsunaga T, Yasuda K, Adachi T, Gu N, Yamamura T, Moritani T, Tsujimoto G, Tsuda K.

Am Heart J. 2007 Oct;154(4):759-66.

PMID:
17893006
12.

Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study.

Covolo L, Gelatti U, Metra M, Nodari S, Piccichè A, Pezzali N, Zani C, Alberti A, Donato F, Nardi G, Dei Cas L.

Eur Heart J. 2004 Sep;25(17):1534-41.

PMID:
15342173
13.

Enhanced beta-adrenergic-mediated cardiovascular responses in endurance athletes.

Hopkins MG, Spina RJ, Ehsani AA.

J Appl Physiol (1985). 1996 Feb;80(2):516-21.

PMID:
8929593
14.

Association between beta-1 and beta-2 adrenergic receptor gene polymorphisms and the response to beta-blockade in patients with stable congestive heart failure.

de Groote P, Helbecque N, Lamblin N, Hermant X, Mc Fadden E, Foucher-Hossein C, Amouyel P, Dallongeville J, Bauters C.

Pharmacogenet Genomics. 2005 Mar;15(3):137-42.

PMID:
15861037
15.

Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy.

Badenhorst D, Norton GR, Sliwa K, Brooksbank R, Essop R, Sareli P, Woodiwiss AJ.

Pharmacogenomics J. 2007 Oct;7(5):339-45. Epub 2006 Nov 21.

PMID:
17117186
16.

Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction.

Yilmaz A, Kaya MG, Merdanoglu U, Ergun MA, Cengel A, Menevse S.

J Clin Lab Anal. 2009;23(4):237-43. doi: 10.1002/jcla.20327.

PMID:
19623647
17.

Cardiac reserve in the transplanted heart: effect of a graft polymorphism in the beta1-adrenoceptor.

Scharin Täng M, Lindberg E, Grüner Sveälv B, Magnusson Y, Andersson B.

J Heart Lung Transplant. 2007 Sep;26(9):915-20.

PMID:
17845930
18.

Blunted cardiac responses to receptor activation in subjects with Thr164Ile beta(2)-adrenoceptors.

Brodde OE, Büscher R, Tellkamp R, Radke J, Dhein S, Insel PA.

Circulation. 2001 Feb 27;103(8):1048-50.

19.

Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.

Aleong RG, Sauer WH, Robertson AD, Liggett SB, Bristow MR.

Circ Arrhythm Electrophysiol. 2013 Feb;6(1):137-43. doi: 10.1161/CIRCEP.111.969618. Epub 2012 Dec 30.

20.

Dobutamine-stress magnetic resonance microimaging in mice : acute changes of cardiac geometry and function in normal and failing murine hearts.

Wiesmann F, Ruff J, Engelhardt S, Hein L, Dienesch C, Leupold A, Illinger R, Frydrychowicz A, Hiller KH, Rommel E, Haase A, Lohse MJ, Neubauer S.

Circ Res. 2001 Mar 30;88(6):563-9.

Supplemental Content

Support Center